Search results
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Dea
Guru Focus· 3 days agoThe stock market exhibited mixed results at the close today. The Nasdaq Composite edged down by...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 19 hours agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 2 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris...
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 7 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WKBN 27 Youngstown· 4 days ago...neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30 patients from Phase 2 company-sponsored trial and regulatory guidance both in H2 2024Selected move-forward Phase 2 dose for IDE397 in MTAP squamous NSCLC, based on clinical efficacy...
AstraZeneca withdraws Covid vaccine as demand dives
Medical Xpress· 2 days agoAnglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing COVID vaccine Vaxzevria, one of the first produced in the deadly pandemic,...
'Pandemic proof' vaccine could beat coronaviruses we don't even know about yet
The US Sun· 4 days agoBRITISH scientists reckon they can make a vaccine for coronaviruses we do not even know about yet....
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into F
Guru Focus· 5 hours agoSangamo Therapeutics Inc (SGMO, Financial), a leader in genomic medicine, disclosed its 8-K filing on May 9, 2024, revealing detailed insights into its first quarter financials and recent strategic ...